Wave Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WVE and other ETFs, options, and stocks.

About WVE

Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. 

CEO
Paul B. Bolno
CEOPaul B. Bolno
Employees
317
Employees317
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2012
Founded2012
Employees
317
Employees317

WVE Key Statistics

Market cap
779.33M
Market cap779.33M
Price-Earnings ratio
-3.64
Price-Earnings ratio-3.64
Dividend yield
—
Dividend yield—
Average volume
2.92M
Average volume2.92M
High today
$4.03
High today$4.03
Low today
$3.82
Low today$3.82
Open price
$3.96
Open price$3.96
Volume
3.16M
Volume3.16M
52 Week high
$21.73
52 Week high$21.73
52 Week low
$3.82
52 Week low$3.82

Stock Snapshot

The current Wave Life Sciences(WVE) stock price is $3.92, with a market capitalization of 779.33M. The stock trades at a price-to-earnings (P/E) ratio of -3.64.

During the trading session on 2026-09-24, Wave Life Sciences(WVE) shares reached a daily high of $4.03 and a low of $3.82. At a current price of $3.92, the stock is +2.5% higher than the low and still -2.7% under the high.

Trading volume for Wave Life Sciences(WVE) stock has reached 3.16M, versus its average volume of 2.92M.

Over the past 52 weeks, Wave Life Sciences(WVE) stock has traded between a high of $21.73 and a low of $3.82.

Over the past 52 weeks, Wave Life Sciences(WVE) stock has traded between a high of $21.73 and a low of $3.82.

WVE News

Investing.com 2d
Wave Life Sciences starts Phase 2a obesity trial for WVE-007 - Investing.com

...

Wave Life Sciences starts Phase 2a obesity trial for WVE-007 - Investing.com
Nasdaq 2d
Wave Life Sciences Names Monika Vnuk Chief Business Officer

(RTTNews) - On Tuesday, Wave Life Sciences Ltd. (WVE), a clinical-stage biotechnology company based in RNA medicines, announced the appointment of Monika Vnuk a...

Wave Life Sciences Names Monika Vnuk Chief Business Officer

Analyst ratings

94%

of 18 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.